IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — DBX

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents1.061.210.730.740.940.520.520.550.600.510.330.370.350.450.690.890.85
Accounts Receivable0.080.070.070.080.070.070.070.070.060.060.060.050.050.040.040.050.05
Total Current Assets1.271.451.081.111.331.051.231.341.471.381.401.581.591.622.062.072.03
Property, Plant & Equipment0.340.360.380.360.360.350.320.320.300.300.310.280.300.320.350.340.33
Goodwill0.460.460.450.450.440.440.410.400.400.400.400.350.350.360.350.350.35
Intangible Assets0.020.030.040.040.050.060.060.050.070.070.080.040.050.050.050.050.05
Total Non-current Assets*1.561.581.711.671.621.531.491.461.541.561.591.121.171.231.281.261.27
Total Assets2.833.032.802.782.962.582.722.803.012.942.992.702.762.853.343.333.31
Accounts Payable0.040.030.040.040.030.040.040.030.050.040.040.030.030.020.020.030.03
Total Current Liabilities1.181.181.901.861.841.201.181.171.201.181.151.161.141.121.181.131.07
Total Non-current Liabilities*3.843.872.422.232.201.921.911.912.162.172.212.142.172.202.332.302.32
Total Liabilities5.015.044.334.084.033.123.093.073.363.353.363.293.303.323.503.423.39
Retained Earnings(4.02)(3.92)(3.63)(3.49)(3.34)(2.99)(2.87)(2.81)(2.87)(2.90)(2.83)(2.97)(2.93)(2.85)(2.64)(2.55)(2.51)
Total Stockholder Equity(2.19)(2.01)(1.53)(1.31)(1.08)(0.55)(0.37)(0.28)(0.35)(0.41)(0.37)(0.59)(0.54)(0.46)(0.16)(0.09)(0.08)

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue631.50629.50636.20634.40625.70624.70643.60638.80634.50631.30635.00633.00622.50611.10598.80591.00572.70562.40565.50550.20
Cost of Revenue125.00128.10132.10128.30123.70116.70120.80111.50107.00105.80122.00119.60120.10116.80115.80109.70105.80112.90115.80112.00
Gross Profit506.50501.40504.10506.10502.00508.00522.80527.30527.50525.50513.00513.40502.40494.30483.00481.30466.90449.50449.70438.20
Research & Development188.10184.20186.90182.30184.40178.40243.00225.70227.10219.10222.10216.40262.80235.20238.50227.60215.00210.80201.90187.30
Selling, General & Admin63.8057.5060.3057.6058.8053.8062.9063.3060.9054.1061.3060.0060.0055.8057.3056.8055.3053.5055.3057.90
Total Operating Expenses341.70328.60341.90331.40333.60324.20434.90399.50400.50382.00245.60382.70445.90410.20563.40392.00384.00360.00379.50360.90
Operating Income164.80172.80162.20174.70168.40183.8087.90127.80127.00143.50267.40130.7056.5084.10(80.40)89.3082.9089.5070.2077.30
Pretax Income117.70141.40143.10157.20147.80169.5092.40132.70133.60151.10272.30135.5059.0087.60(78.40)98.2079.1093.8085.8076.10
Tax Provision21.9026.9034.4033.4022.2019.20(10.40)26.0023.1018.8045.0021.4015.8018.60(406.70)15.0017.1014.10(38.80)0.50
Net Income95.80114.50108.70123.80125.60150.30102.80106.70110.50132.30227.30114.1043.2069.00328.3083.2062.0079.70124.6075.60
Basic EPS0.430.490.440.470.460.520.340.340.340.400.660.340.130.200.910.230.170.220.320.20
Diluted EPS0.420.480.430.470.450.510.330.340.340.390.650.330.130.200.910.230.170.210.320.19

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow238.50204.50235.40302.10260.50153.80213.80274.20230.60175.50200.30255.90187.60139.90194.60251.40209.90141.40162.70231.50
Capital Expenditures3.301.2010.508.402.000.103.304.105.909.2010.009.403.001.9012.906.204.0010.701.3010.00
Free Cash Flow*235.20203.30224.90293.70258.50153.70210.50270.10224.70166.30190.30246.50184.60138.00181.70245.20205.90130.70161.40221.50
Investing Cash Flow19.2066.9045.9017.8012.4035.80113.80153.1063.20113.70(22.00)10.30206.10200.80(105.10)7.50(51.90)101.0035.30(182.90)
Financing Cash Flow(410.00)46.20(140.80)(323.60)(487.80)(578.50)523.90(431.10)(326.70)(352.70)(172.00)(168.60)(217.30)(241.30)(234.10)(232.50)(246.40)(328.80)(352.30)(243.90)

* Derived from reported values